Ticagrelor-induced Diarrhea in a Patient with Acute Coronary Syndrome Requiring Percutaneous Coronary Artery Intervention

The P2Y(12) inhibitor, ticagrelor, has been shown to prevent thrombotic events and hence, improve morbidity and mortality in patients with acute coronary syndrome following coronary artery stent placement. Despite many clinical benefits, ticagrelor has been associated with several adverse effects, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Alomari, Mohammad, Bratton, Hunter, Musmar, Ahmad, Al Momani, Laith A, Young, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414296/
https://www.ncbi.nlm.nih.gov/pubmed/30899625
http://dx.doi.org/10.7759/cureus.3874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414296/
https://www.ncbi.nlm.nih.gov/pubmed/30899625
http://dx.doi.org/10.7759/cureus.3874

Ejemplares similares